insights_auto
Why is HLUBF up 15.91%?
Dive Deeperchevron_right
HLUBF:OTCMKTS
H Lundbeck A/S Class A
$7.94
arrow_upward
+15.91%(+1.09) 1D
Nov 9, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLUBF...
Open
$7.94
High
$7.94
Low
$7.94
Mkt. cap
55.30B
Avg. vol.
108.00
Volume
141.00
52-wk high
$7.94
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
Open
$7.94
High
$7.94
Low
$7.94
Mkt. cap
55.30B
Avg. vol.
108.00
Volume
141.00
52-wk high
$7.94
52-wk low
$4.82
Beta
0.85
Shares outstanding
199.15M
No. of employees
5K
News stories
From web sources and news partners
KELO-AM
·
6 hours ago
Lundbeck hikes annual forecasts as migraine drug powers earnings beat
The Pharma Letter
·
10 hours ago
Lundbeck raises full-year guidance as 9 month revenue grows
Investing.com
·
14 hours ago
Why is H Lundbeck stock surging today?
Profile
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine. Wikipedia
About H Lundbeck A/S Class A
CEOCharl Van Zyl
Employees5K
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitelundbeck.com